Essay --

The United States of America accounts for only 5% of the worlds population, besides as a nation, we devour over 50% of the worlds pharmaceutical medication and around 80% of the worlds ethical drug narcotics (American Addict). The increasing demand for prescription medication in America has elicited a national health crisis in which the government and big assembly line benefit at the expense of the American public.(II) The enacting of Medicare Part D in 2006 only helped to fuel Americas hunger for prescription medication. In 2003, President George W. Bush announced and signed the Medicare Prescription Drug, Improvement, and Modernization deport (also known as the Medicare Modernization figure, or MMA) on December 8th. The almost $400 billion dollar measure was marketed to the American public as something that will provide care for the millions of senior citizens who, at the time, were struggling to grant prescription medication. This was the largest development of Medicare s ince 1965, which is when the program was initially created, and gave hope to those wishing for overbearing medical reform. According to title XI of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the most significant change will be the affordability of prescription drugs by implementing the importation of drugs from Canada, along with necessary safety measures, in order to fall the cost (United States Congress, 832). For those who were in retirement homes and lacked a steady income, the affordability of drugs was often a deciding factor in the decision to seek medical management and the idea that those individuals ceased to live simply beca consumption they lacked the funds tugged at the heartstrings of many Americans. Although the Medicare Moderniza... ...pecially with the use of DTC advertising, to such a wide range of afflictions greatly increased their consumer base, except one of them proved to be deadly. In 1999, four years by and by Lilly sen t study results to the U.S. Food and Drug Administration showing Zyprexa didnt alleviate dementia symptoms in older patients, it began marketing the drug to those very(prenominal) people, according to documents unsealed in insurer suits against the company for overpayment.(Applbaum, 248). Soon later it began to be used in those suffering from dementia, there were studies produces that showed an increase in death rate among elderly patients taking Zyprexa. In January of 2009, Eli Lilly and Company, who produced the drug, ended up settling the lawsuit and agreed to pay $1.415 billion which was one of the biggest corporal settlements in the history of pharmaceutical companies (Applbaum, 237).